I 115th CONGRESS 1st Session H. R. 2026 IN THE HOUSE OF REPRESENTATIVES April 6, 2017 Mr. Guthrie introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To improve patient access to emerging medication therapies by clarifying the scope of permitted health care economic and scientific information communications between biopharmaceutical manufacturers and population health decision makers.